AUAUniversity21 Kesä 2023

Global Advancements in Bladder Cancer

Based on the findings from the 2022 AUA global survey and needs assessment in bladder cancer, the AUA has developed this new series of virtual courses to update urologists on the latest advancements in bladder cancer care. This course will address new and emerging treatment options for non‐muscle invasive (NMIBC) and muscle‐invasive bladder cancer (MIBC) with a focus on identifying side effects and interventions, review of guidelines specific to first and second line therapies, timing and usage of neoadjuvant and adjuvant systemic therapy, BCG shortage and the urologists role in clinical trial enrollment. Currently available agents as well as those in development will be discussed. CME Available: https://auau.auanet.org/node/38615 Release Date: June, 2023 Expiration Date: June, 2024 ACKNOWLEDGEMENTS This educational series is supported by an independent educational grant from AstraZeneca. After participating in this educational series, participants will be able to: 1. Delineate key factors to risk stratify patients with NMIBC and MIBC. 2. Review guidelines focused on first‐ and second‐line therapies for NMIBC and MIBC. 3. Describe emerging treatment options with intravesical and systemic therapies for patients in an era of BCG shortage and for patients with BCG unresponsive disease and determine the appropriate timing and use of neoadjuvant and adjuvant systemic therapy for invasive bladder cancer. 4. Identify side effects and possible interventions to ameliorate side effects for these therapies. 5. Recognize the urologist’s role in clinical trials and how to overcome obstacles to clinical trial enrollment.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(448)

AUA2026: Focus on: ADT in the Modern Era

AUA2026: Focus on: ADT in the Modern Era - Balancing Cancer Control and Cardiovascular Safety CME Available: https://cme.auanet.org/URL/FOCUS265ONL LEARNING OBJECTIVES: After participating in this C...

15 Heinä 1h 9min

Innovations in the Surgical Management of BPH (2026)

Innovations in the Surgical Management of BPH (2026) CME Available: https://cme.auanet.org/URL/surgical-treatment-bph-2026 LEARNING OBJECTIVES: After participating in this educational series, parti...

8 Heinä 36min

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicin...

1 Heinä 35min

AUA Guidelines: Advanced Prostate Cancer

AUA Guidelines: Advanced Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Kristen R. Scarpato, MD, MPH To access the full guideline, please use the following link: https://www.auanet.org/...

24 Kesä 22min

AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)

AUA2026: Focus on: Metastatic Urothelial Carcinoma CME Available: https://cme.auanet.org/URL/FOCUS264ONL LEARNING OBJECTIVES: After participating in this CME activity, participants will be able to: ...

17 Kesä 1h 7min

AUA Guidelines: Clinically Localized Prostate Cancer

AUA Guidelines: Clinically Localized Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: James Eastham, MD, FACS To access the full guideline, please use the following link: https://www.auan...

10 Kesä 28min

Update Series (2026): Kidney Stones and the Infected Patient

Update Series (2026): Kidney Stones and the Infected Patient Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Mantu Gupta, MD Now in its 45th installment, the AUA Update Series is renowned for delivering...

3 Kesä 21min

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast CME Available: https://cme.auanet.org/URL/FOCUS262ONL LEARNING OBJECTIVES: After participating in this CME activity...

27 Touko 1h 15min